Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome

Front Med (Lausanne). 2024 Mar 4:11:1327505. doi: 10.3389/fmed.2024.1327505. eCollection 2024.

Abstract

A patient presenting with several basal cell carcinomas, pigmented nevi, and developmental defects was diagnosed with nevoid basal cell carcinoma syndrome. Gene panel sequencing and Sanger sequencing were used to identify a novel heterozygous frameshift mutation, c.1312dupA:p.Ser438Lysfs, in exon 9 of PTCH1. I-Tasser and PyMol analyses indicated that the mutated protein patched homolog 1 (PTCH1) lacked 12 transmembrane domains and the intracellular and extracellular rings of ECD2 compared with the wild-type protein, resulting in a remarkably different structure from that of the wild-type protein. This case extends our knowledge of the mutation spectrum of NBCCS.

Keywords: PTCH1; case report; frameshift mutation; nevoid basal cell carcinoma syndrome; novel.

Publication types

  • Case Reports

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported Young Talents in Medical Science and Technology (2023RC009) and 2023 Basic Research Program of Shanxi Province (Free exploration, 202303021221224) to HC.